Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
7.45
-0.37 (-4.73%)
Dec 20, 2024, 4:00 PM EST - Market closed
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $509.41 million as of December 20, 2024. Its market cap has increased by 7.72% in one year.
Market Cap
509.41M
Enterprise Value
693.73M
1-Year Change
7.72%
Ranking
Category
Stock Price
$7.45
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has decreased from $527.13M to $509.41M, a decrease of -3.36%. That is a compound annual growth rate of -0.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 509.41M | -2.55% |
| Dec 29, 2023 | 522.72M | 13.23% |
| Dec 30, 2022 | 461.63M | -22.48% |
| Dec 31, 2021 | 595.53M | -36.35% |
| Dec 31, 2020 | 935.68M | 22.51% |
| Dec 31, 2019 | 763.76M | 44.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xeris Biopharma Holdings | 520.29M |
| CorMedix | 520.00M |
| Mereo BioPharma Group | 518.91M |
| Sangamo Therapeutics | 515.36M |
| Semler Scientific | 512.07M |
| Talkspace | 503.39M |
| Auna S.A. | 501.16M |
| EyePoint Pharmaceuticals | 498.14M |